Did the FDA Ban Compounded Semaglutide and Tirzepatide? CVS Caremark is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. DETAILS Medicare, Medicaid to experiment with covering weight loss drugs The Washington Post Japanese Mounjaro Recipe for Weight Loss Macie Medical